Elnoamany Hossam
Neurosurgical Department, Faculty of Medicine, Menoufia University Hospital, Shebin El Kom, Menoufia, Egypt.
Asian Spine J. 2015 Apr;9(2):178-84. doi: 10.4184/asj.2015.9.2.178. Epub 2015 Apr 15.
This was a prospective cohort study.
The purpose of this study was to document and evaluate the clinical and radiological results of percutaneous vertebroplasty (PV) as a first line treatment in traumatic non-osteoporotic vertebral compression fractures (TNVCFs).
PV is commonly used for osteoporotic and neoplastic compression fractures, however its use in traumatic non-osteoporotic compression fractures is uncertain.
We included 23 patients with traumatic non-osteoporotic TNVCFs and normal bone mineral densitometry scores who were treated with PV. Pain was evaluated at 2 hours, 1 week, 1 month, 6 months, 1 year, and 2 years post procedure using the 10-point visual analogue scale (VAS). Ronald-Morris disability Questionnaire (RDQ) scores were also collected. Statistical analysis included a 2-tailed t test comparing postoperative data with preoperative values. Range of mobility was also evaluated.
The 23 patients had an average age of 36 years, and 69.5% were female. There was a significant improvement in VAS scores of pain at rest and in motionand in RDQ scores (p<0.05).
The results of this study proved that PV can be used successfully as a first line treatment in patients with non-osteoporotic compression fractures. It is also, an effective method to decrease pain, increase mobility, and decrease narcotic administration.
这是一项前瞻性队列研究。
本研究的目的是记录和评估经皮椎体成形术(PV)作为创伤性非骨质疏松性椎体压缩骨折(TNVCFs)一线治疗方法的临床和放射学结果。
PV常用于骨质疏松性和肿瘤性压缩骨折,但其在创伤性非骨质疏松性压缩骨折中的应用尚不确定。
我们纳入了23例接受PV治疗的创伤性非骨质疏松性TNVCFs且骨密度测量评分正常的患者。在术后2小时、1周、1个月、6个月、1年和2年使用10分视觉模拟量表(VAS)评估疼痛情况。还收集了罗纳德 - 莫里斯残疾问卷(RDQ)评分。统计分析包括使用双尾t检验比较术后数据与术前值。还评估了活动范围。
23例患者的平均年龄为36岁,69.5%为女性。静息和活动时的VAS疼痛评分以及RDQ评分均有显著改善(p<0.05)。
本研究结果证明PV可成功用于非骨质疏松性压缩骨折患者的一线治疗。它也是一种减轻疼痛、增加活动能力和减少麻醉剂使用的有效方法。